Cervical Cancer: Resource Overview

Cervical cancer incidence and mortality has declined substantially over the last several decades with improved cervical cancer screening. Ob-gyns, physicians whose primary responsibility is women’s health, play a leading role in cervical cancer prevention, screening, diagnosis, and treatment, including evidence-based management of abnormal Pap and HPV test results.

Here are the key publications and resources for ob-gyns, other women’s health care providers, and patients from the American College of Obstetricians and Gynecologists (ACOG) and other sources.

Jump to:
Resources for Ob-Gyns and Women’s Health Care Providers
Resources for Women and Patients

Resources for Ob-Gyns and Women’s Health Care Providers

Practice Bulletin: Cervical Cancer Screening and Prevention (members only)

“Cervical Cancer Screening and Prevention,” issued by ACOG in October 2016, provides a review of the best available evidence for cervical cancer screening. This guideline covers cervical cytology (Pap test) screening techniques and test reporting, and human papillomavirus (HPV) vaccination and testing.

Practice Bulletin: Management of Abnormal Cervical Cancer Screening Test Results and Cervical Cancer Precursors (members only)

“Management of Abnormal Cervical Cancer Screening Test Results and Cervical Cancer Precursors,” issued by ACOG in December 2013 (reaffirmed 2016), is an evidence-based guideline that defines when to return to routine screening after treatment or resolution of abnormalities, updates the incorporation of HPV testing, and integrates new data on the risk of high-grade precursor lesions and cancer.

Statement of Policy: Cervical Cancer Prevention in Low-Resource Settings (members only)

“Cervical Cancer Prevention in Low-Resource Settings,” issued by ACOG in March 2004 (reaffirmed 2011), addresses the need for more cost-effective ways to prevent cervical cancer in low-resource settings, especially developing countries. It affirms that there is growing evidence that a single-visit approach, incorporating visual inspection of the cervix with acetic acid wash (VIA), followed by an immediate offer of treatment with cryotherapy for eligible lesions, is safe, acceptable, and cost-effective. 


Resources for Women and Patients

Patient Fact Sheet: New Guidelines for Cervical Cancer Screening

“New Guidelines for Cervical Cancer Screening,” issued by ACOG in September 2013, provides women with the latest recommendations for Pap and HPV testing.

Patient FAQ: Cervical Cancer

“Cervical Cancer,” issued by ACOG in December 2015, explains that it takes several years for cervical cancer to develop. It covers HPV infection as a cause, risk factors, screening with the Pap test and HPV test, symptoms, diagnosis, staging, and treatment.

Patient FAQ: Loop Electrosurgical Excision Procedure (LEEP)

“Loop Electrosurgical Excision Procedure (LEEP),” issued by ACOG in July 2014, explains how this procedure may be used after an abnormal cervical cancer screening result for evaluation and treatment. LEEP is one way to remove abnormal cells from the cervix.

Patient FAQ: Abnormal Cervical Cancer Screening Test Results

“Abnormal Cervical Cancer Screening Test Results,” issued by ACOG in January 2016, explains the causes and types of abnormal cervical cancer screening results, what testing is needed after an abnormal test result, and treatment options for abnormal cervical cells.


The American College of Obstetricians and Gynecologists (ACOG), a 501(c)(3) organization, is the nation’s leading group of physicians providing health care for women. As a private, voluntary, nonprofit membership organization of more than 58,000 members, ACOG strongly advocates for quality women’s health care, maintains the highest standards of clinical practice and continuing education of its members, promotes patient education, and increases awareness among its members and the public of the changing issues facing women’s health care.


American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998